Dr Reddy's Laboratories (Dr Reddy's Laboratories) EV-to-EBITDA : 11.48 (As of Apr. 28, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr Reddy's Laboratories's enterprise value is $11,785 Mil. Dr Reddy's Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,026 Mil. Therefore, Dr Reddy's Laboratories's EV-to-EBITDA for today is 11.48.

The historical rank and industry rank for Dr Reddy's Laboratories's EV-to-EBITDA or its related term are showing as below:

RDY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.17 Med: 14.51 Max: 27.99
Current: 11.65

During the past 13 years, the highest EV-to-EBITDA of Dr Reddy's Laboratories was 27.99. The lowest was 9.17. And the median was 14.51.

RDY's EV-to-EBITDA is ranked better than
57.91% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.19 vs RDY: 11.65

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Dr Reddy's Laboratories's stock price is $74.55. Dr Reddy's Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.787. Therefore, Dr Reddy's Laboratories's PE Ratio for today is 19.69.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Dr Reddy's Laboratories EV-to-EBITDA Historical Data

The historical data trend for Dr Reddy's Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories EV-to-EBITDA Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBITDA

Get a 7-Day Free Trial

13.34

16.30

18.52

15.62

9.67

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															9.66	9.67	10.29	10.61	10.75

Competitive Comparison of Dr Reddy's Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's EV-to-EBITDA falls into.

Dr Reddy's Laboratories EV-to-EBITDA Calculation

Dr Reddy's Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	11784.642	/	1026.154
	=	11.48

Dr Reddy's Laboratories's current Enterprise Value is $11,785 Mil.
Dr Reddy's Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,026 Mil.

Dr Reddy's Laboratories (NYSE:RDY) EV-to-EBITDA Explanation

Dr Reddy's Laboratories's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	74.55	/	3.787
	=	19.69

Dr Reddy's Laboratories's share price for today is $74.55.
Dr Reddy's Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.787.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Dr Reddy's Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » EV-to-EBITDA

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.